Table of Contents
ISRN Neurology
Volume 2011, Article ID 374314, 6 pages
http://dx.doi.org/10.5402/2011/374314
Research Article

Mgat5 Deficiency in T Cells and Experimental Autoimmune Encephalomyelitis

1Department of Neurology, University of California, Irvine, CA 92868-4280, USA
2Institute for Immunology, University of California, Irvine, CA 92697-4120, USA
3Department of Microbiology and Molecular Genetics, University of California, Irvine, CA 92697-4025, USA

Received 9 April 2011; Accepted 30 April 2011

Academic Editors: P. Armati, M.-C. Chartier-Harlin, and J.-I. Satoh

Copyright Β© 2011 Ani Grigorian and Michael Demetriou. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. C. Ebers, A. D. Sadovnick, N. J. Risch et al., β€œA genetic basis for familial aggregation in multiple sclerosis,” Nature, vol. 377, no. 6545, pp. 150–151, 1995. View at Google Scholar
  2. G. C. Ebers, D. E. Bulman, and A. D. Sadovnick, β€œA population-based study of multiple sclerosis in twins,” New England Journal of Medicine, vol. 315, no. 26, pp. 1638–1642, 1986. View at Google Scholar Β· View at Scopus
  3. S. E. Baranzini, J. Mudge, J. C. Van Velkinburgh et al., β€œGenome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis,” Nature, vol. 464, no. 7293, pp. 1351–1356, 2010. View at Publisher Β· View at Google Scholar Β· View at Scopus
  4. K. L. Munger, S. M. Zhang, E. O'Reilly et al., β€œVitamin D intake and incidence of multiple sclerosis,” Neurology, vol. 62, no. 1, pp. 60–65, 2004. View at Google Scholar Β· View at Scopus
  5. D. A. Dyment, A. D. Sadovnick, C. J. Willer et al., β€œAn extended genome scan in 442 Canadian multiple sclerosis-affected sibships a report from the Canadian Collaborative Study Group,” Human Molecular Genetics, vol. 13, no. 10, pp. 1005–1015, 2004. View at Publisher Β· View at Google Scholar Β· View at Scopus
  6. B. Brynedal, K. Duvefelt, G. Jonasdottir et al., β€œHLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis,” PLoS ONE, vol. 2, no. 7, article e664, 2007. View at Publisher Β· View at Google Scholar Β· View at Scopus
  7. S. G. Gregory, S. Schmidt, P. Seth et al., β€œInterleukin 7 receptor Ξ± chain (IL7R) shows allelic and functional association with multiple sclerosis,” Nature Genetics, vol. 39, no. 9, pp. 1083–1091, 2007. View at Publisher Β· View at Google Scholar Β· View at Scopus
  8. F. Lundmark, K. Duvefelt, E. Iacobaeus et al., β€œVariation in interleukin 7 receptor Ξ± chain (IL7R) influences risk of multiple sclerosis,” Nature Genetics, vol. 39, no. 9, pp. 1108–1113, 2007. View at Publisher Β· View at Google Scholar Β· View at Scopus
  9. A. T. Arthur, P. J. Armati, C. Bye et al., β€œGenes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission,” BMC Medical Genetics, vol. 9, article 17, 2008. View at Publisher Β· View at Google Scholar Β· View at Scopus
  10. B. Brynedal, J. Wojcik, F. Esposito et al., β€œMGAT5 alters the severity of multiple sclerosis,” Journal of Neuroimmunology, vol. 220, no. 1-2, pp. 120–124, 2010. View at Publisher Β· View at Google Scholar Β· View at Scopus
  11. H. Schachter, β€œThe β€œyellow brick road” to branched complex N-glycans,” Glycobiology, vol. 1, no. 5, pp. 453–461, 1991. View at Google Scholar Β· View at Scopus
  12. R. Kornfeld and S. Kornfeld, β€œAssembly of asparagine-linked oligosaccharides,” Annual Review of Biochemistry, vol. 54, pp. 631–664, 1985. View at Google Scholar Β· View at Scopus
  13. H. Mkhikian, A. Grigorian, C. F. Li et al., β€œGenetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis,” Nature Communications, vol. 2, article 334, 2011. View at Google Scholar
  14. A. Grigorian, S. Torossian, and M. Demetriou, β€œT-cell growth, cell surface organization, and the galectin-glycoprotein lattice,” Immunological Reviews, vol. 230, no. 1, pp. 232–246, 2009. View at Publisher Β· View at Google Scholar Β· View at Scopus
  15. K. S. Lau, E. A. Partridge, A. Grigorian et al., β€œComplex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation,” Cell, vol. 129, no. 1, pp. 123–134, 2007. View at Publisher Β· View at Google Scholar Β· View at Scopus
  16. M. Demetriou, M. Granovsky, S. Quaggin, and J. W. Dennis, β€œNegative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation,” Nature, vol. 409, no. 6821, pp. 733–739, 2001. View at Publisher Β· View at Google Scholar Β· View at Scopus
  17. S. U. Lee, A. Grigorian, J. Pawling et al., β€œN-glycan processing deficiency promotes spontaneous inflammatory demyelination and neurodegeneration,” Journal of Biological Chemistry, vol. 282, no. 46, pp. 33725–33734, 2007. View at Publisher Β· View at Google Scholar Β· View at Scopus
  18. L. Steinman, β€œMultiple sclerosis: two-stage disease,” Nature Immunology, vol. 2, no. 9, pp. 762–764, 2001. View at Publisher Β· View at Google Scholar Β· View at Scopus
  19. C. Tranchant, K. P. Bhatia, and C. D. Marsden, β€œMovement disorders in multiple sclerosis,” Movement Disorders, vol. 10, no. 4, pp. 418–423, 1995. View at Publisher Β· View at Google Scholar Β· View at Scopus
  20. A. Grigorian, S. U. Lee, W. Tian et al., β€œControl of T cell-mediated autoimmunity by metabolite flux to N-glycan biosynthesis,” Journal of Biological Chemistry, vol. 282, no. 27, pp. 20027–20035, 2007. View at Publisher Β· View at Google Scholar Β· View at Scopus
  21. R. C. Calvert, M. Shabbir, C. S. Thompson, D. P. Mikhailidis, R. J. Morgan, and G. Burnstock, β€œImmunocytochemical and pharmacological characterisation of P2-purinoceptor-mediated cell growth and death in PC-3 hormone refractory prostate cancer cells,” Anticancer Research, vol. 24, no. 5 A, pp. 2853–2859, 2004. View at Google Scholar Β· View at Scopus
  22. M. A. Toscano, G. A. Bianco, J. M. Ilarregui et al., β€œDifferential glycosylation of T1, T2 and T-17 effector cells selectively regulates susceptibility to cell death,” Nature Immunology, vol. 8, no. 8, pp. 825–834, 2007. View at Publisher Β· View at Google Scholar Β· View at Scopus
  23. C. C. Motran, K. M. Molinder, S. D. Liu, F. Poirier, and M. C. Miceli, β€œGalectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function,” European Journal of Immunology, vol. 38, no. 11, pp. 3015–3027, 2008. View at Publisher Β· View at Google Scholar Β· View at Scopus
  24. C. Zhu, A. C. Anderson, A. Schubart et al., β€œThe Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity,” Nature Immunology, vol. 6, no. 12, pp. 1245–1252, 2005. View at Publisher Β· View at Google Scholar Β· View at Scopus
  25. I. J. Chen, H. L. Chen, and M. Demetriou, β€œLateral compartmentalization of T cell receptor versus CD45 by galectin-N-glycan binding and microfilaments coordinate basal and activation signaling,” Journal of Biological Chemistry, vol. 282, no. 48, pp. 35361–35372, 2007. View at Publisher Β· View at Google Scholar Β· View at Scopus
  26. H. L. Chen, C. F. Li, A. Grigorian, W. Tian, and M. Demetriou, β€œT cell receptor signaling co-regulates multiple golgi genes to enhance N-glycan branching,” Journal of Biological Chemistry, vol. 284, no. 47, pp. 32454–32461, 2009. View at Publisher Β· View at Google Scholar Β· View at Scopus
  27. V. K. Tuohy, M. Yu, L. Yin et al., β€œThe epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis,” Immunological Reviews, vol. 164, pp. 93–100, 1998. View at Publisher Β· View at Google Scholar Β· View at Scopus
  28. E. A. Partridge, C. Le Roy, G. M. Di Guglielmo et al., β€œRegulation of cytokine receptors by golgi N-glycan processing and endocytosis,” Science, vol. 306, no. 5693, pp. 120–124, 2004. View at Publisher Β· View at Google Scholar Β· View at Scopus
  29. R. S. Green, E. L. Stone, M. Tenno, E. Lehtonen, M. G. Farquhar, and J. Marth, β€œMammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis,” Immunity, vol. 27, no. 2, pp. 308–320, 2007. View at Publisher Β· View at Google Scholar Β· View at Scopus
  30. J. M. Ilarregui, D. O. Croci, G. A. Bianco et al., β€œTolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10,” Nature Immunology, vol. 10, no. 9, pp. 981–991, 2009. View at Publisher Β· View at Google Scholar Β· View at Scopus
  31. Z. Ye and J. D. Marth, β€œN-glycan branching requirement in neuronal and postnatal viability,” Glycobiology, vol. 14, no. 6, pp. 547–558, 2004. View at Publisher Β· View at Google Scholar Β· View at Scopus
  32. R. Patani, M. Balaratnam, A. Vora, and R. Reynolds, β€œRemyelination can be extensive in multiple sclerosis despite a long disease course,” Neuropathology and Applied Neurobiology, vol. 33, no. 3, pp. 277–287, 2007. View at Publisher Β· View at Google Scholar Β· View at Scopus
  33. M. Sakaguchi, T. Shingo, T. Shimazaki et al., β€œA carbohydrate-binding protein, Galectin-1, promotes proliferation of adult neural stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 18, pp. 7112–7117, 2006. View at Publisher Β· View at Google Scholar Β· View at Scopus